GUGGENHIME ANDREW 4
4 · Vaxcyte, Inc. · Filed Sep 4, 2025
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
GUGGENHIME ANDREW
PRESIDENT AND CFO
Transactions
- Tax Payment
Common Stock
2025-09-02$31.56/sh−1,270$40,081→ 131,009 total - Tax Payment
Common Stock
2025-09-02$31.56/sh−2,381$75,144→ 128,628 total - Tax Payment
Common Stock
2025-09-02$31.56/sh−1,429$45,099→ 127,199 total
Footnotes (2)
- [F1]Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- [F2]Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.